Summary The aim of this study was to see if antibiotic pastilles could reduce radiation mucositis, pain, dysphagia and weight loss in patients undergoing radical radiotherapy for head and neck cancer. A total of 275 patients with T -T4 tumours entered the study; 136 were allocated to suck four times daily a pastille containing amphotericin, polymyxin and tobramycin. The During treatment, cells in the basal layers of the mucous membranes within the irradiated volume are unable to replace adequately cells lost through inactivation or exfoliation. The resultant mucosal damage may then be exacerbated by colonisation of the affected area by abnormal microbial flora. Mucositis has a number of manifestations that may be seen at different times depending on the volume irradiated, the total dose and the fractionation schedule. Initially, there may be a transient white discolouration, followed by deepening erythema and later a white pseudomembrane which may be patchy or confluent. The most severe manifestation is ulceration of the mucosa.
Mucositis following therapeutic irradiation of patients suffering from head and neck cancer is a reactive inflammatory process within the normal tissues of the upper airways or upper digestive tract. Severe mucositis can produce pain, difficulty in eating, drinking and speech. The patient may lose weight and the overall general condition can deteriorate markedly. The severity of symptoms may force the clinician to stop radiotherapy prematurely or give the patient a rest from treatment. Both actions can lead to tumour persistence.
During treatment, cells in the basal layers of the mucous membranes within the irradiated volume are unable to replace adequately cells lost through inactivation or exfoliation. The resultant mucosal damage may then be exacerbated by colonisation of the affected area by abnormal microbial flora. Mucositis has a number of manifestations that may be seen at different times depending on the volume irradiated, the total dose and the fractionation schedule. Initially, there may be a transient white discolouration, followed by deepening erythema and later a white pseudomembrane which may be patchy or confluent. The most severe manifestation is ulceration of the mucosa.
In health, the very diverse oropharyngeal flora contains a marked preponderance of anaerobic bacteria together with a near universal presence of lesser numbers of viridans streptococci and Neisseria species. Irradiation, local tumour and surgery can all interfere with the mucosal defences important for the maintenance of this ecological balance. In consequence, there is frequent overgrowth of organisms rarely seen in health and then only at low concentrations. Overgrowth of yeasts and aerobic Gram-negative bacilli (in particular Enterobacteriaceae, Pseudomonads and Acinetobacter) has attracted particular attention in the context of irradiation mucositis (van Saene and Martin, 1990) .
There are no established effective measures to prevent or treat mucositis. Standard therapy is to maintain good oral hygiene and prescribe analgesics if necessary. A small study by Spijkervert et al. (1991) described a novel approach to this problem. Lozenges containing polymyxin E, tobramycin and amphotericin B were used to eradicate selectively aerobic Gram-negative bacteria (AGNB) and yeasts from the oropharynx while retaining the normal anaerobic and aerobic flora. This selective decontamination regimen was given to 15 patients with head and neck cancer treated by radiotherapy. An excellent microbiological result was obtained and mucositis was confined to erythema in all patients. By contrast, matched historical controls treated with a placebo or chlorhexidene showed an 80% incidence of more severe mucositis with pseudomembrane formation.
The aim of the study was to use a placebo-controlled double-blind trial to test the hypothesis that the more severe forms of irradiation mucositis are associated with abnormal carriage of AGNB and yeasts and that selective reduction of these microbial populations with non-absorbable antibiotics would reduce both the signs and symptoms of mucositis.
Materials and methods
Patients receiving potentially curative radiotherapy for T-4 head and neck cancer were entered into this trial. Both arms of the study are well balanced after randomisation for age, sex, T and N stage, histology and total mean radiation dose (Table II) . Those with an unknown T stage were patients with lymph node metastasis from an undiscovered primary head and neck cancer. There was a slight imbalance between the two arms in terms of site of primary disease. This is due to the fact that most nasopharynx patients had the active pastilles. If the analysis is repeated omitting this site, the same end points have statistically significant differences, although in general the level of significance is reduced. Over the eight assessment weeks patients were asked whether or not they were still taking the pastilles. As a measure of compliance the percentage of weeks assessed where the patient responded 'yes' to this question was calculated. These data are summarised in Table III and shows that compliance was good.
In this randomised double-blind trial the antibioticcontaining pastilles had a beneficial effect both on observed differences in appearance, in the degree of mucositis and also the functional consequences (Table IV) . The primary study The functional consequences of mucositis were significantly reduced in the active arm, severity of dysphagia (P= 0.006), and especially the highly objective end point, percentage weight loss (P = 0.009) ( Table V) . The reduction in pain was just short of statistical significance (P = 0.056). Figure 1 shows the number of patients whose mouth washings yielded yeast isolates in each of the weeks after No. of weeks after starting treatment Figure 1 Yeast isolates during and after radiotherapy. In contrast, the active pastilles failed to reduce the percentage of patients with AGNB cultured during treatment (P = 0.256), irrespective of whether or not these bacteria were cultured before treatment (Table VII) . There was a consistent reduction in the proportion of treated patients whose mouth washings yielded AGNB in any one week (Figure 2 ), but this effect was only seen from week 3 of treatment and reached statistical significance in only 3 of the 7 weeks affected.
The mouth washings yielded a wide range of AGNB species, with a preponderance of coliform strains (Table  VIII) . Isolates from the pastille and placebo groups showed no significant difference in the distribution of AGNB species.
The relationship of the microbiological results to No. of weeks after starting treatment Figure 2 Aerobic Gram-negative bacilli isolates during and after radiotherapy.
pseudomembrane formation is of particular interest because pseudomembranes are generally accepted as an index of severe mucositis. There was no significant association between treatment group and the incidence of resistance among AGNB to the pastille drugs, and this finding was not affected by the detection of resistant AGNB strains in pretreatment samples. However, following the onset of treatment, a significant minority (13%) of all pastille patients showed at least one isolate of a resistant strain (mainly Proteus or Serratia species resistant to polymyxin). Outgrowth of resistant Grampositive organisms (including enterococci) was not seen and there were no clinical problems associated with antibiotic resistance.
For both active and placebo pastilles, patient groups with higher treatment compliance had about a 25% smaller incidence of patients with positive yeast cultures. In contrast, compliance had no significant effect on the isolation of AGNB (Table XII) . The reduced isolation of yeasts in the placebo group is at first sight surprising. However, it is likely that patients who used the pastilles as prescribed were also conscientious in following advice about oral hygiene and these procedures may have affected the oral flora as revealed in the mouthwash samples. The absence of a compliance effect on AGNB, together with the disappointing effect of active-pastilles against these organisms, suggests that reduction of oral microbial populations by whatever means may be more difficult with AGNB than with yeasts. There is no standard therapy to prevent or treat radiation mucositis. The use of the antiseptic mouthwash chlorhexidene has been shown to be ineffective (Skijhervet et al., 1989b) or even harmful (Foote et al., 1994) . Soluble aspirin has been popular for many years as a treatment for this condition but it has never been tested in a randomised controlled trial. It is possible that the anti-inflammatory properties of aspirin are important along with its analgesic effects. Benzydamine, a non-steroid anti-inflammatory agent with anaesthetic and antimicrobial properties was tested in a double-blind placebocontrolled trial containing 43 patients. The degree of mucositis was statistically significantly reduced and there was a non-significant trend in the reduction of radiationinduced symptoms in favour of the active arm (Epstein et al., 1989) . Other agents, in particular sucralfate, a coating agent which binds to ulcerated areas, have shown promise in small uncontrolled studies but have not been found to be effective when assessed more rigorously (Epstein and Wong, 1994) .
This large, randomised, placebo-controlled, double-blind trial shows significant, beneficial effects of a selective decontamination regimen applied to the buccal mucosa and oropharynx. There was a reduction in mucositis distribution (P=0.002), mucositis area (P=0.028), dysphagia (P=0.006) and especially weight loss (P= 0.009) which is a highly objective end point. These results support the findings of a small, uncontrolled study when 15 patients were given lozenges containing the same antibiotics (Spijkervet et al., 1991) . However, our findings are less striking. In particular, the formation of pseudomembranes was inhibited rather than completely prevented as described by Spijkervet and colleagues.
Pseudomembrane formation is important, both because it is an index of severe mucositis and because it is the principal feature that distinguishes irradiation mucositis from yeast stomatitis. The latter is an acute infection of the buccal mucosa characterised by burning, tenderness or dryness and the presence of white patches or deep red erosions. Pseudomembranes consist of extruded plasma and dead cells and their formation probably results from the combined effects of irradiation damage and abnormal microbial colonisation of the damaged mucosa. Both yeasts and AGNB have been implicated in the microbial component, and it has been suggested that AGNB are the principal factor (Spijkervet et al., 1991; Martin, 1993) . The results of this study strongly suggest that yeast colonisation is a major factor in the pathogenesis of the condition. However, they are also compatible with an important role for AGNB, particularly in the formation of the more advanced grades of pseudomembranes. More investigation is required to elucidate the complex microbiological features of this condition.
The significant clinical benefit demonstrated with pastille use probably relates to effects on both yeast stomatitis and irradiation mucositis. Any effects of the pastilles in preventing yeast stomatitis can reasonably be ascribed to the amphotericin B component of the formulation. However, the reduction in pseudomembrane formation may reflect a complex interaction between the marked antifungal effect of the amphotericin B combined with the less striking effect shown by the two antibacterial agents against AGNB.
The high proportion (76%) of patients in the active group who suffered some form of pseudomembrane formation may have resulted from the limited ability of the pastille regimen to reduce oral mucosal populations of AGNB. This disappointing microbiological result contrasts strongly with the use of the same antibacterials applied as a gel or paste to the buccal mucosa in intensive care patients, when AGNB populations are drastically reduced within 3 -4 days (Stoutenbeek et al., 1984; Ledingham et al., 1988) . The striking success of the latter regimens may well reflect prolonged drug exposure of mucosal organisms resulting from the adherent gel or paste preparations used. This feature, combined with the partial success of pastilles in the present study, suggests a need for new formulations to allow protracted delivery of antimicrobials to the buccal mucosa of ambulant patients.
In spite of these reservations, the present study has demonstrated that the use of pastilles containing tobramycin, polymyxin and amphotericin produced a reduction in mucositis problems that should be of sufficient magnitude to increase materially patient tolerance to radical radiotherapy for head and neck cancer.
